USANA Health Sciences Inc Stock Research

Market Summary

USD62.77+0.87

Market Closed

1.41%

USNA Alerts

4 major insider sales recently.

USNA Stock Price

USNA RSI Chart

USNA Valuation

Market Cap

1.2B

Price/Earnings (Trailing)

18.56

Price/Sales (Trailing)

1.24

EV/EBITDA

7.8

Price/Free Cashflow

14.03

USNA Price/Sales (Trailing)

USNA Profitability

EBT Margin

10.88%

Return on Equity

15.96%

Return on Assets

11.63%

Free Cashflow Yield

7.13%

USNA Fundamentals

USNA Revenue

Revenue (TTM)

974.1M

Revenue Y/Y

-8.98%

Revenue Q/Q

8.95%

USNA Earnings

Earnings (TTM)

65.3M

Earnings Y/Y

-18.19%

Earnings Q/Q

43.67%

Price Action

52 Week Range

48.6176.58

(Low)(High)

Last 7 days

-2.3%

Last 30 days

-7.6%

Last 90 days

2.2%

Trailing 12 Months

-11.0%

USNA Financial Health

Current Ratio

2.67

USNA Investor Care

Shares Dilution (1Y)

0.57%

Diluted EPS (TTM)

3.39

Peers (Alternatives to USANA Health Sciences)

View All Peers In Detail

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
PG	357.9B	81.0B	-5.94%	0.62%	25.07	4.46	1.70%	-1.88%
EL	69.6B	15.9B	-19.27%	-18.92%	46.06	4.38	-12.42%	-53.65%
CL	63.2B	18.3B	-0.61%	-1.25%	35.42	3.52	4.93%	-21.82%
CHD	22.9B	311.6M	2.14%	5.32%	55.51	73.52	-94.06%	-49.12%
CLX	19.7B	7.2B	-2.66%	10.48%	265.75	2.74	0.89%	-83.84%
MID-CAP
COTY	9.4B	5.4B	-5.40%	65.12%	48.53	1.75	3.31%	-45.41%
ELF	5.4B	496.6M	7.92%	311.21%	114.96	10.84	30.80%	132.00%
IPAR	4.1B	1.1B	-15.90%	81.46%	29.42	3.58	23.19%	46.99%
EPC	2.1B	2.2B	-5.61%	12.71%	22.11	0.94	4.71%	-20.28%
SMALL-CAP
USNA	1.2B	974.1M	-7.56%	-11.05%	18.56	1.24	-15.40%	-39.77%
MED	893.8M	1.6B	-9.97%	-50.57%	6.31	0.56	4.75%	-13.96%
REV	214.9M	-	-40.09%	-62.17%	-0.3	0.1	-	-56.86%
MTEX	23.8M	137.2M	-12.66%	-47.15%	-5.31	0.17	-14.12%	-145.62%
CYAN	6.4M	25.9M	4.06%	-66.00%	-3.69	0.25	-30.49%	-203.40%

Financials for USANA Health Sciences

* denotes actual numbers (not divided by Millions)
Income Statement (Last 12 Months)					(In Millions)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Revenue	-2.5%	974	999	1,038	1,079	1,151
Gross Profit	-2.7%	783	805	838	875	940
Operating Expenses	-2.2%	682	697	721	740	781
S&GA Expenses	-0.7%	260	262	270	270	276
EBITDA	-6.7%	122	131	148	173	-
EBITDA Margin	-3.1%	0.12*	0.13*	0.14*	0.15*	-
Earnings Before Taxes	-4.4%	104	109	117	135	160
EBT Margin	-3.9%	0.11*	0.11*	0.12*	0.14*	-
Interest Expenses	-0.5%	0.00	0.00	0.00	0.00	0.00
Net Income	-5.9%	65.00	69.00	77.00	89.00	108
Net Income Margin	-6.2%	0.07*	0.07*	0.08*	0.09*	-
Free Cahsflow	19.7%	94.00	78.00	84.00	108	-

Balance Sheet					(In Millions)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Assets	1.5%	606	597	556	558	573
Current Assets	3.0%	396	384	341	342	364
Cash Equivalents	2.4%	295	288	247	230	238
Inventory	-3.9%	64.00	67.00	67.00	84.00	98.00
Net PPE	-1.0%	97.00	98.00	95.00	98.00	101
Goodwill	0.2%	17.00	17.00	17.00	0.00	18.00
Current Liabilities	-9.5%	130	144	126	134	158
Shareholder's Equity	4.8%	455	434	411	404	390
Retained Earnings	4.7%	410	392	379	364	345
Additional Paid-In Capital	1.3%	56.00	56.00	52.00	49.00	46.00
Shares Outstanding	0.5%	19.00	19.00	19.00	19.00	19.00

* denotes actual numbers (not divided by Millions)
Cashflow (Last 12 Months)					(In Millions)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Cashflow From Operations	-6.6%	97.00	104	88.00	97.00	121
Share Based Compensation	3.2%	14.00	13.00	13.00	13.00	14.00
Cashflow From Investing	-12.9%	-13.96	-12.37	-12.24	-15.11	-12.88
Cashflow From Financing	54.5%	-13.69	-30.09	-62.38	-109	-130
Buy Backs	-100.0%	0.00	25.00	57.00	107	137

Risks for USNA

What is the probability of a big loss on USNA?

78.5%

Probability that USANA Health Sciences stock will be more than 20% underwater in next one year

61.1%

Probability that USANA Health Sciences stock will be more than 30% underwater in next one year.

41.9%

Probability that USANA Health Sciences stock will be more than 40% underwater in next one year.

*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does USNA drawdown profile look like?

Y-axis is the maximum loss one would have experienced if USANA Health Sciences was unfortunately bought at previous high price.

Drawdowns

Returns for USNA

Cumulative Returns on USNA

13.7%

10-Year Cumulative Returns

11.0%

7-Year Cumulative Returns

-11.0%

5-Year Cumulative Returns

-9.1%

3-Year Cumulative Returns

What are the long-term rolling returns for USNA?

FIve years rolling returns for USANA Health Sciences.

Annualized Returns

Which funds bought or sold USNA recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
2023-05-23	ROYCE & ASSOCIATES LP	added	12.15	363,518	1,478,590	0.01%
2023-05-22	AMERIPRISE FINANCIAL INC	added	5.05	867,893	4,454,890	-%
2023-05-22	PUTNAM INVESTMENTS LLC	reduced	-3.95	52,030	435,708	-%
2023-05-18	JPMORGAN CHASE & CO	added	7.72	1,104,000	5,135,000	-%
2023-05-18	NEW YORK STATE COMMON RETIREMENT FUND	reduced	-8.83	122,000	1,686,000	-%
2023-05-17	Thrivent Financial for Lutherans	reduced	-3.39	86,000	694,000	-%
2023-05-17	Providence Capital Advisors, LLC	added	6,289	110,057	115,856	-%
2023-05-16	Baker Avenue Asset Management, LP	added	87.5	518	944	-%
2023-05-16	JANE STREET GROUP, LLC	new	-	240,844	240,844	-%
2023-05-16	Rockefeller Capital Management L.P.	sold off	-100	-	-	-%

Latest Funds Activity

Are funds buying USNA calls or puts?

Calls

Puts

Are funds bullish or bearish(Calls - Puts)?

Net Call Options

No. of funds that own USNA

No. of Funds

USNA Alerts

4 major insider sales recently.

USANA Health Sciences News

Schedule 13G FIlings of USANA Health Sciences

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2023	renaissance technologies llc	6.38%	1,224,997	SC 13G/A
Feb 09, 2023	vanguard group inc	7.99%	1,534,910	SC 13G/A
Jan 06, 2023	blackrock inc.	10.2%	1,963,866	SC 13G/A
Feb 11, 2022	renaissance technologies llc	7.48%	1,456,097	SC 13G/A
Feb 10, 2022	vanguard group inc	7.70%	1,498,731	SC 13G/A
Feb 01, 2022	blackrock inc.	9.3%	1,802,996	SC 13G/A
Nov 22, 2021	wentz myron w	41.0%	7,985,743	SC 13D/A
Aug 13, 2021	wentz myron w	39.9%	7,985,743	SC 13D/A
Mar 11, 2021	wentz myron w	38.3%	7,985,743	SC 13D/A
Feb 11, 2021	renaissance technologies llc	8.19%	1,722,966	SC 13G/A

USNA Fair Value

USANA Health Sciences fair value in different scenarios

The table shows the Fair Value estimates for USANA Health Sciences for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.

Fair Value	Very Pessimistic	Pessimistic	Base Case	Optimistic	Very Optimistic
Very Low Inflation	26.83 -57.26%	34.93 -44.35%	43.41 -30.84%	63.45 1.08%	77.41 23.32%
Current Inflation	25.47 -59.42%	32.42 -48.35%	39.88 -36.47%	57.19 -8.89%	69.21 10.26%
Very High Inflation	23.71 -62.23%	29.28 -53.35%	35.52 -43.41%	49.65 -20.90%	59.45 -5.29%

Historical USANA Health Sciences Fair Value Estimates

Very Pessimistic Case

Pessimistic Case

Fair Value

Optimistic Case

Very Optimistic Case

Closing Stock Price

Recent SEC filings of USANA Health Sciences

View All Filings

Date Filed	Form Type	Document
May 19, 2023	144	Notice of Insider Sale Intent
May 12, 2023	8-K/A	Current Report
May 11, 2023	8-K	Current Report
May 10, 2023	144	Notice of Insider Sale Intent
May 09, 2023	10-Q	Quarterly Report
May 09, 2023	4	Insider Trading
May 09, 2023	4	Insider Trading
May 09, 2023	4	Insider Trading
May 08, 2023	144	Notice of Insider Sale Intent
May 05, 2023	144	Notice of Insider Sale Intent

Latest Insider Trading transactions for USNA

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
2023-05-08	Brown Jim	sold	-811,180	66.4793	-12,202	president
2023-05-05	Fleming John Turman	sold	-83,804	67.0432	-1,250	-
2023-05-05	Neidig Brent	sold	-180,389	66.9596	-2,694	co & man. dir. of china
2023-04-29	Neidig Brent	acquired	-	-	467	co & man. dir. of china
2023-04-29	Neidig Brent	sold (taxes)	-13,805	66.37	-208	co & man. dir. of china
2023-04-28	Mulham David Mulham	sold	-76,699	67.3984	-1,138	chief sales officer
2023-04-28	Nixon J Scott	sold	-164,879	67.2977	-2,450	-
2023-04-28	FULLER GILBERT A	sold	-27,088	67.0504	-404	-
2023-04-27	Winssinger Frederic J	sold	-134,508	67.2542	-2,000	-
2023-04-25	Winssinger Frederic J	acquired	-	-	404	-

About USANA Health Sciences

Kevin G. Guest

www.usana.com

1980

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

USNA Income Statement

2023-04-01

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Income Statement [Abstract]
Net sales	$ 248,360	$ 272,867
Cost of sales	48,519	51,383
Gross profit	199,841	221,484
Operating expenses:
Associate incentives	106,070	119,620
Selling, general and administrative	66,926	68,797
Total operating expenses	172,996	188,417
Earnings from operations	26,845	33,067
Other income (expense):
Interest income	1,775	739
Interest expense	(31)	(32)
Other, net	(88)	(487)
Other income (expense), net	1,656	220
Earnings before income taxes	28,501	33,287
Income taxes	10,118	10,818
Net earnings	$ 18,383	$ 22,469
Earnings per common share
Earnings per share, basic (in dollars per share)	$ 0.95	$ 1.16
Earnings per share, diluted (in dollars per share)	$ 0.95	$ 1.15
Weighted average common shares outstanding
Basic (in shares)	19,283	19,351
Diluted (in shares)	19,328	19,481
Comprehensive income:
Net earnings	$ 18,383	$ 22,469
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment	1,654	(691)
Tax benefit (expense) related to foreign currency translation adjustment	98	(546)
Other comprehensive income (loss), net of tax	1,752	(1,237)
Comprehensive income	$ 20,135	$ 21,232

USNA Balance Sheet

2023-04-01

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Apr. 01, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 295,454	$ 288,420
Inventories	64,490	67,089
Prepaid expenses and other current assets	35,934	28,873
Total current assets	395,878	384,382
Property and equipment, net	96,798	97,773
Goodwill	17,411	17,368
Intangible assets, net	31,971	32,432
Deferred tax assets	7,868	9,799
Other assets	55,607	54,795
Assets, total	605,533	596,549
Current liabilities
Accounts payable	10,511	11,049
Other current liabilities	119,711	132,784
Total current liabilities	130,222	143,833
Deferred tax liabilities	5,575	4,071
Other long-term liabilities	14,382	14,173
Stockholders' equity
Common stock, $0.001 par value; Authorized -- 50,000 shares, issued and outstanding 19,294 as of April 1, 2023 and 19,206 as of December 31, 2022	19	19
Additional paid-in capital	56,351	55,604
Retained earnings	410,019	391,636
Accumulated other comprehensive income (loss)	(11,035)	(12,787)
Total stockholders' equity	455,354	434,472
Liabilities and equity, total	$ 605,533	$ 596,549